Abstract
Research supporting the effectiveness and safety of medications for young children in low- and middle-income countries (LMIC) can only be generated if high-quality randomized controlled trials are designed, conducted, and reported appropriately. Clinical research in LMIC is associated with ethical and scientific risks beyond those observed in high-income countries. Scientific challenges of clinical research in LMIC include the need to contain risks of trial bias related to attrition and blinding, definition of the role of data monitoring committees, valid measurement of relevant and standardized outcomes, and inclusion of the appropriate paediatric age sub-groups; ethical challenges particular to clinical research in LMIC include conduct of placebo-controlled clinical trials despite HIC availability of effective comparator interventions, obtaining informed consent despite power inequities, and the obligation to redress health disparities in LMIC. This chapter addresses challenges and proposes ways to navigate these challenges through awareness, regulatory oversight, consultation, and strengthened collaboration with investigators and communities.
Keywords
- Vaccine Trial
- Data Monitoring Committee
- Paediatric Trial
- Paediatric Clinical Trial
- Child Health Research
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J. 2000;320:79–82.
t’Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. Unapproved and off-label use of drugs in a children’s hospital. N Engl J Med. 2000;343:1125.
Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med. 2008;5:e172.
Cohen E, Uleryk E, Jasuja M, Parkin PC. An absence of pediatric randomized controlled trials in general medical journals, 1985–2004. J Clin Epidemiol. 2007;60:118–23.
Wittmeier KD, Craig J, Klassen TP, Offringa M. The mission of StaR Child Health is to improve the quality of the design, conduct, and reporting of pediatric clinical research by promoting the use of modern research standards. Introduction. Pediatrics. 2012;129 Suppl 3:S111.
Standards for Research (StaR) in Child Health. http://www.starchildhealth.org. Accessed 15 Oct 2014.
Klassen TP, Hartling L, Hamm M, van der Lee JH, Ursum J, Offringa M. StaR Child Health: an initiative for RCTs in children. Lancet. 2009;374:1310–2.
Frakking FN, van der Lee JH, Klassen TP, Offringa M for the STaR-Child Health Group. Survey of current guidance for child health clinical trials. The StaR Child Health Project: standards for research in children. 2009. www.who.int/childmedicines/publications/GUIDANCECHILDHEALTH.pdf. Accessed 14 Oct 2014.
Council of Canadian Academies. Improving current approaches to paediatric efficacy studies. In: Improving Medicines for Children in Canada. 2014. http://www.scienceadvice.ca/en/news.aspx?id=139. Accessed 15 Oct 2014.
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. Br Med J. 2013;346:e7586.
Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;11:32.
Bernard C. An introduction to the study of experimental medicine. 2nd ed. New York: Dover Publications; 1957.
Shuster E. Fifty years later: the significance of the Nuremberg Code. N Engl J Med. 1997;337:1436–40.
World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Seoul: Amended by the World Medical Association 59th General Assembly; 2008.
Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Geneva: Council for International Organizations of Medical Sciences; 2002.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Belmont Report. Ethical principles and guidelines for the protection of human subjects of research. Washington: Government Printing Office; 1988. GPO 887–809.
Nuffield Council on Bioethics. Ethical issues in research in developing countries. London: Nuffield Council on Bioethics discussion paper; 1999.
National Bioethics Advisory Commission. Ethical and policy issues in international research. Washington: National Bioethics Advisory Commission; 2000.
Weijer C, Emanuel EJ. Protecting communities in biomedical research. Science. 2000;289:1142–4.
Annas GJ, Grodin MA. Human rights and maternal-fetal HIV transmission prevention trials in Africa. Am J Public Health. 1998;88:560–3.
Gambia Hepatitis Study Group. Hepatitis B vaccine in the expanded programme on immunization: the Gambian experience. Lancet. 1989;i:1057–60.
Mulholland EK, Hilton S, Adegbola R, Usen S, Oparaugo A, Omoshigo C, et al. Randomised trial of a Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet. 1997;349:1191–7.
Vimolket T, Theamboonlers A, Dumas R, Milcamps B, Forrat R, Poovorawan Y. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults. Southeast Asian J Trop Med Public Health. 1998;29:779–85.
Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, et al. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis. 2014;14:119–29.
Watanaveeradej V, Gibbons RV, Simasathien S, Nisalak A, Jarman RG, Kerdpanich A, et al. Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial. Am J Trop Med Hyg. 2014;91:119–28.
Mulholland K. Pneumococcal conjugate vaccine relevance for developing countries. Indian Pediatr. 2001;38:453–60.
Varmus H, Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med. 1997;337:1003–5.
Benatar SR, Singer PA. A new look at international research ethics. Br Med J. 2000;321:824–6.
Copenhagen (World Pharma 2010). Challenges in the conduct of pediatric clinical trials in low and middle income countries. http://www.micyrn.ca/francais/PDF/starfinal.pdf. Accessed 16 Oct 2014.
Kass N, Hyder A. Attitudes and experiences of US and developing country investigators regarding US human subjects regulations. In: National Bioethics Advisory Commission, editor. Ethical and policy issues in international research: clinical trials in developing countries, vol. II. Bethesda: National Bioethics Advisory Commission; 2001.
Bhutta ZA. Ethics in international health research: a perspective from the developing world. Bull World Health Organ. 2002;80:114–20.
Bhutta ZA. Beyond informed consent. Bull World Health Organ. 2004;82:771–7.
Acknowledgement
Dr. William van’t Hoff from the Somers Clinical Research Facility, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, helped in preparing parts of this text.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bhutta, Z.A., Offringa, M. (2015). Standards of Research for Clinical Trials in Low- and Middle-Income Countries. In: MacLeod, S., Hill, S., Koren, G., Rane, A. (eds) Optimizing Treatment for Children in the Developing World. Adis, Cham. https://doi.org/10.1007/978-3-319-15750-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-15750-4_14
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-15749-8
Online ISBN: 978-3-319-15750-4
eBook Packages: MedicineMedicine (R0)